United StatesLevothyroxine Sodium Tablets USP 150 mcg in 1000‑tablet bottles (NDC 33342‑401‑44), Lot 16240062A, exp. 3/2026, manufactured for Macleods Pharma USA, Inc. (manufactured by Macleods Pharmaceuticals Ltd.) are affected. They were recalled nationwide because they are subpotent; 1,315 bottles are included in the ongoing recall.
What's being recalled
Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44
Recalling firm: Macleods Pharma USA, Inc, Princeton, NJ, United States.
How to identify it
Lot 16240062A, exp date 3/2026
The hazard
Subpotent Drug
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)